(Q30924390)

27 June 2017

title

Intervention thresholds for osteoporosis in men and women: a study based on data from Sweden (English)

1 reference

27 June 2017

0 references

0 references

3

Anders Oden

1 reference

27 June 2017

1

John A Kanis

1 reference

27 June 2017

5

Helena Johansson

1 reference

27 June 2017

2

Olof Johnell

1 reference

27 June 2017

Frederik Borgstrom

4

1 reference

27 June 2017

Chris De Laet

series ordinal

6

1 reference

27 June 2017

Bengt Jönsson

series ordinal

7

1 reference

27 June 2017

language of work or name

English

0 references

publication date

22 April 2004

1 reference

Osteoporosis International

27 June 2017

published in

1 reference

27 June 2017

volume

16

1 reference

27 June 2017

issue

1

1 reference

27 June 2017

page(s)

6-14

1 reference

The association of radiographically detected vertebral fractures with back pain and function: a prospective study

27 June 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00198-004-1623-4

Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00198-004-1623-4

Accounting for future costs in medical cost-effectiveness analysis

21 January 2018

1 reference

12 December 2020

Effect and offset of effect of treatments for hip fracture on health outcomes

1 reference

12 December 2020

The apparent incidence of hip fracture in Europe: a study of national register sources

1 reference

12 December 2020

Excess mortality after hospitalisation for vertebral fracture

1 reference

12 December 2020

The components of excess mortality after hip fracture

1 reference

12 December 2020

Effect of raloxifene on the risk of new vertebral fracture in postmenopausal women with osteopenia or osteoporosis: a reanalysis of the Multiple Outcomes of Raloxifene Evaluation trial

1 reference

12 December 2020

The burden of osteoporotic fractures: a method for setting intervention thresholds

1 reference

12 December 2020

The Sheffield table for primary prevention of coronary heart disease: corrected

1 reference

12 December 2020

Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture

1 reference

12 December 2020

Preference for fractures and other glucocorticoid-associated adverse effects among rheumatoid arthritis patients

1 reference

12 December 2020

International variations in hip fracture probabilities: implications for risk assessment

1 reference

12 December 2020

Mortality after all major types of osteoporotic fracture in men and women: an observational study.

1 reference

12 December 2020

The Relationship Between Bone Density and Incident Vertebral Fracture in Men and Women

1 reference

12 December 2020

Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group

1 reference

12 December 2020

Treatment of established osteoporosis: a systematic review and cost-utility analysis.

1 reference

12 December 2020

Diagnosis of osteoporosis and assessment of fracture risk

1 reference

12 December 2020

Meta-analyses of therapies for postmenopausal osteoporosis. I. Systematic reviews of randomized trials in osteoporosis: introduction and methodology

1 reference

12 December 2020

Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study

1 reference

12 December 2020

Estimating the Costs of Hip Fracture and Potential Savings

1 reference

12 December 2020

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group

1 reference

12 December 2020

Symptomatic fracture incidence in elderly men and women: the Dubbo Osteoporosis Epidemiology Study (DOES)

1 reference

12 December 2020

Cost-effectiveness of preventing hip fracture in the general female population.

1 reference

12 December 2020

The cost of a hip fracture. Estimates for 1,709 patients in Sweden

1 reference

12 December 2020

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

1 reference

12 December 2020

At what coronary risk level is it cost-effective to initiate cholesterol lowering drug treatment in primary prevention?

1 reference

12 December 2020

What is the true mortality of hip fractures?

1 reference

12 December 2020

Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield table

1 reference

12 December 2020

An update on the diagnosis and assessment of osteoporosis with densitometry. Committee of Scientific Advisors, International Osteoporosis Foundation

1 reference

12 December 2020

Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures

1 reference

12 December 2020

Cost-effectiveness of fracture prevention in established osteoporosis.

1 reference

12 December 2020

Inpatient hospital and post-acute care for vertebral fractures in women

1 reference

12 December 2020

Cost-effectiveness of intense insulin treatment after acute myocardial infarction in patients with diabetes mellitus; results from the DIGAMI study

1 reference

12 December 2020

Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group

1 reference

12 December 2020

Hip fracture prediction in elderly men and women: validation in the Rotterdam study.

1 reference

12 December 2020

Population-based study of survival after osteoporotic fractures

1 reference

12 December 2020

1 reference

12 December 2020

Lifetime risk of hip fractures is underestimated

1 reference

12 December 2020

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

12 December 2020

Risk of Mortality Following Clinical Fractures

1 reference

12 December 2020

The variable incidence of hip fracture in southern Europe: the MEDOS Study

1 reference

12 December 2020

Effect of alendronate on limited-activity days and bed-disability days caused by back pain in postmenopausal women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

12 December 2020

Fracture incidence in Olmsted County, Minnesota: comparison of urban with rural rates and changes in urban rates over time

1 reference

12 December 2020

Impact of hip and vertebral fractures on quality-adjusted life years.

1 reference

12 December 2020

International comparison of hip fracture rates in 1988-89.

1 reference

12 December 2020

Cost-equivalence of different osteoporotic fractures

1 reference

12 December 2020

Direct medical costs attributable to osteoporotic fractures

1 reference

12 December 2020

NICE: faster access to modern treatments? Analysis of guidance on health technologies

1 reference

12 December 2020

Statin therapy--what now?

1 reference

12 December 2020

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

1 reference

12 December 2020

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

12 December 2020

Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

1 reference

12 December 2020

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

1 reference

12 December 2020

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

1 reference

12 December 2020

Postmenopausal estrogens in prevention of osteoporosis. Benefit virtually without risk if cardiovascular effects are considered

1 reference

12 December 2020

Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis

1 reference

12 December 2020

Intervention thresholds for osteoporosis

1 reference

12 December 2020

Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen

1 reference

12 December 2020

The skeletal response to teriparatide is largely independent of age, initial bone mineral density, and prevalent vertebral fractures in postmenopausal women with osteoporosis

1 reference

12 December 2020

Incorporating future costs in medical cost-effectiveness analysis: implications for the cost-effectiveness of the treatment of hypertension

1 reference

12 December 2020

Osteoporosis in men and women: a story about bone mineral density thresholds and hip fracture risk.

1 reference

12 December 2020

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

1 reference

12 December 2020

Diagnosis of osteoporosis and fracture threshold in men.

1 reference

12 December 2020

Economic evaluation of interventions for osteoporosis

1 reference

12 December 2020

Osteoporosis: review of the evidence for prevention, diagnosis and treatment and cost-effectiveness analysis. Executive summary

1 reference

12 December 2020

The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation

1 reference

12 December 2020

10.1007/S00198-004-1623-4

Identifiers

DOI

1 reference

27 June 2017

1 reference